Evidence map›Paper›PMID 30545015›Full record

ReviewDiseases (Basel, Switzerland)2018

Strategic Syntheses of Vine and Wine Resveratrol Derivatives to Explore their Effects on Cell Functions and Dysfunctions.

Norbert Latruffe, Dominique Vervandier-Fasseur

Open access · goldAbstract readReview
In one paragraph

Review in Diseases (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. A Comprehensive Study on the Antimicrobial Properties of Resveratrol as an Alternative Therapy.Evidence-based complementary and alternative medicine : eCAM · 2021
    Review
  8. Review
  9. Review
  10. The Potential Use of Resveratrol for Cancer Prevention.Molecules (Basel, Switzerland) · 2019
    Review
  11. Review
  12. Special Issue: Wine and Vine Components and Health.Diseases (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Norbert LatruffeBiochemistry of the Peroxisome, Inflammation and Lipid Metabolism, EA 7270, Université de Bourgogne Franche-Comté, 6, boulevard Gabriel, 21078 DIJON CEDEX, France. norbert.latruffe@u-bourgogne.fr.ORCID 0000-0001-6794-2690
Dominique Vervandier-FasseurInstitut de Chimie Moléculaire de l'Université de Bourgogne, ICMUB-UMR CNRS 6302, Université de Bourgogne Franche-Comté, 9, avenue A. Savary, 21078 DIJON CEDEX, France. dominique.vervandier-fasseur@u-bourgogne.fr.ORCID 0000-0002-2998-5873
Centre National de la Recherche Scientifique · FRUniversité de Bourgogne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biological targetsefficacy towards diseasesresveratrol derivativessubstituents phenyl ringssynthesis strategies

Identifiers

PMID30545015
PMCPMC6313602
OpenAlexW2904315529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.